Xeris Biopharma Holdings Ratios (2020-2026) | XERS

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter)
62.01%70.89%77.19%71.58%80.99%82.30%81.02%83.98%80.12%83.03%82.95%85.31%83.79%74.95%84.23%85.48%83.37%85.22%87.24%87.28%
EBT Margin (Quarter)
-308.95%-235.16%-237.02%-154.59%-104.81%-74.58%-40.03%-50.71%-53.98%-25.93%-30.70%-45.95%-29.66%-35.13%-8.51%-15.34%-2.70%0.83%12.91%2.69%
EBIT Margin (Quarter)
-289.55%-220.24%-225.26%-131.72%-74.75%-63.18%-45.77%-40.00%-42.04%-10.17%-22.17%-35.05%-17.03%-23.76%2.79%-5.14%6.27%9.05%19.55%9.52%
EBITDA Margin (Quarter)
-289.55%-220.24%-225.26%-131.72%-74.75%-63.18%-45.77%-40.00%-42.04%-10.17%-22.17%-35.05%-17.03%-23.76%2.79%-5.14%6.27%9.05%19.55%9.52%
Operating Margin (Quarter)
-289.55%-220.24%-225.26%-131.72%-74.75%-63.18%-45.77%-40.00%-42.04%-10.17%-22.17%-35.05%-17.03%-23.76%2.79%-5.14%6.27%9.05%19.55%9.52%
Net Margin (Quarter)
-308.95%-235.16%-237.02%-152.74%-103.47%-73.44%-39.01%-50.71%-52.20%-25.23%-30.16%-46.71%-31.22%-29.00%-8.51%-15.34%-2.70%0.83%12.91%2.69%
FCF Margin (Quarter)
-224.81%-204.44%-135.69%-219.31%-81.44%-59.73%-48.63%-78.74%-36.16%-30.24%16.83%-49.96%-21.53%-15.30%3.29%-16.69%0.25%24.78%23.36%11.87%
Efficiency
Inventory Average (Quarter)
16.18M17.50M17.38M19.00M22.43M26.89M32.79M37.34M38.49M39.86M41.93M44.05M46.65M50.43M59.99M67.37M68.07M71.45M
Assets Average (Quarter)
217.81M320.99M328.12M310.82M323.77M332.94M325.07M328.28M325.19M329.61M334.17M326.42M322.08M319.26M325.07M352.44M376.86M387.77M
Invested Capital (Quarter)
14.96M16.64M17.52M1.02M0.42M15.06M15.10M11.96M
Asset Utilization Ratio (Quarter)
0.230.200.240.320.340.360.410.470.500.520.540.570.630.700.760.760.770.81
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-14.33-13.53-26.58-2.68-0.24-1.82-3.47-1.35-1.85-0.57-1.22-1.65-0.95-1.490.28-0.360.150.783.210.92
Debt Ratio (Quarter)
0.670.290.410.430.460.540.630.620.630.590.690.700.720.770.770.650.590.570.56
Times Interest Earned (Quarter)
-14.33-13.53-26.58-2.68-0.24-1.82-3.47-1.35-1.85-0.57-1.22-1.65-0.95-1.490.28-0.360.150.783.210.92
Valuation
Enterprise Value (Quarter)
-92.98M-102.43M-132.15M-111.55M-93.43M-121.97M-95.10M-80.67M-65.97M-72.45M-87.35M-77.57M-69.40M-71.62M-58.44M-59.28M-91.60M-111.04M-111.75M
Return Ratios
Return on Sales (Quarter)
-0.03%-0.02%-0.02%-0.02%-0.01%-0.01%0.00%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter)
-82.98%-50.09%-45.76%-47.49%-32.76%-26.30%-25.76%-20.45%-19.13%-17.53%-14.37%-19.19%-15.18%-10.03%-4.27%4.15%9.31%13.34%
Return on Invested Capital (Quarter)
-0.03%-0.01%-0.01%-0.01%-0.01%-0.02%-0.01%-0.01%0.00%
Return on Assets (Quarter)
-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%